145 related articles for article (PubMed ID: 2680347)
21. Ultraviolet light-induced modification of crosslinked hyaluronan gels.
Ramamurthi A; Vesely I
J Biomed Mater Res A; 2003 Aug; 66(2):317-29. PubMed ID: 12889002
[TBL] [Abstract][Full Text] [Related]
22. [Research progress of viscosupplementation].
Gu Q; Zhou N; Shanghai J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):755-60. PubMed ID: 21735794
[TBL] [Abstract][Full Text] [Related]
23. Viscosupplementation for osteoarthritis.
Wright KE; Maurer SG; Di Cesare PE
Am J Orthop (Belle Mead NJ); 2000 Feb; 29(2):80-8; discussion 88-9. PubMed ID: 10695858
[TBL] [Abstract][Full Text] [Related]
24. Nociceptive nerve activity in an experimental model of knee joint osteoarthritis of the guinea pig: effect of intra-articular hyaluronan application.
Gomis A; Miralles A; Schmidt RF; Belmonte C
Pain; 2007 Jul; 130(1-2):126-36. PubMed ID: 17197090
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronan therapy: looking toward the future.
Kelly MA; Moskowitz RW; Lieberman JR
Am J Orthop (Belle Mead NJ); 2004 Feb; 33(2 Suppl):23-8. PubMed ID: 15005297
[TBL] [Abstract][Full Text] [Related]
26. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
Conrozier T; Vignon E
Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
[TBL] [Abstract][Full Text] [Related]
27. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation.
Pelletier JP; Martel-Pelletier J
J Rheumatol Suppl; 1993 Aug; 39():19-24. PubMed ID: 8410880
[TBL] [Abstract][Full Text] [Related]
28. Use of Hylan G-F 20 for viscosupplementation of the temporomandibular joint for the management of osteoarthritis: a case report.
Yustin D; Kryshtalskyj B; Galea A
J Orofac Pain; 1995; 9(4):375-9. PubMed ID: 8995909
[TBL] [Abstract][Full Text] [Related]
29. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
Goldberg VM; Coutts RD
Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
[TBL] [Abstract][Full Text] [Related]
30. A novel hydrogel crosslinked hyaluronan with glycol chitosan.
Wang W
J Mater Sci Mater Med; 2006 Dec; 17(12):1259-65. PubMed ID: 17143757
[TBL] [Abstract][Full Text] [Related]
31. The effect of hyaluronan on bone and soft tissue and immune response in wound healing.
Engström PE; Shi XQ; Tronje G; Larsson A; Welander U; Frithiof L; Engstrom GN
J Periodontol; 2001 Sep; 72(9):1192-200. PubMed ID: 11577951
[TBL] [Abstract][Full Text] [Related]
32. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
[TBL] [Abstract][Full Text] [Related]
33. Weekly injections of Hylan G-F 20 delay cartilage degeneration in partial meniscectomized rat knees.
Yanagisawa K; Muneta T; Ozeki N; Nakagawa Y; Udo M; Saito R; Koga H; Tsuji K; Sekiya I
BMC Musculoskelet Disord; 2016 Apr; 17():188. PubMed ID: 27118194
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: a randomised placebo-controlled trial.
Munteanu SE; Zammit GV; Menz HB; Landorf KB; Handley CJ; Elzarka A; Deluca J
Ann Rheum Dis; 2011 Oct; 70(10):1838-41. PubMed ID: 21791454
[TBL] [Abstract][Full Text] [Related]
35. A Randomized Controlled Trial on the Efficacy and Safety of a New Crosslinked Hyaluronan Gel in Reducing Adhesions after Gynecologic Laparoscopic Surgeries.
Liu C; Lu Q; Zhang Z; Xue M; Zhang Y; Zhang Y; Wang H; Li H; Zhou Y; Zhang Z; Li W;
J Minim Invasive Gynecol; 2015; 22(5):853-63. PubMed ID: 25906706
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis.
Tikiz C; Unlü Z; Sener A; Efe M; Tüzün C
Clin Rheumatol; 2005 Jun; 24(3):244-50. PubMed ID: 15647968
[TBL] [Abstract][Full Text] [Related]
38. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications.
Waddell DD
Drugs Aging; 2007; 24(8):629-42. PubMed ID: 17702533
[TBL] [Abstract][Full Text] [Related]
39. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
[TBL] [Abstract][Full Text] [Related]
40. Viscosupplementation: techniques, indications, results.
Legré-Boyer V
Orthop Traumatol Surg Res; 2015 Feb; 101(1 Suppl):S101-8. PubMed ID: 25596987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
